EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Temporal trends in medication and service use patterns for mental health issues among men with prostate cancer

Tenaw Tiruye iD, Mrunal Hiwase, Megan Charlick, Michael O'Callaghan, Ashna Khalid, Ming Li, Liesel M FitzGerald, Gillian E Caughey, Kerry Ettridge, David Roder iD, Kerri Beckmann iD

Psycho-Oncology · 2024

DOI: 10.1002/pon.6369 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Psycho-Oncology, 2024. Verfasst von Tenaw Tiruye und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Epidemiology and Population Health Research Group, Allied Health and Human Performance, University of South Australia, Adelaide, South Austral…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Mental Health Services, Psychotropic Drugs. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Movember Foundation, Cancer Council South Australia, Government of South Australia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Prostate cancer can significantly impact mental wellbeing, creating uncertainty and morbidity. This study described patterns of psychotropic medication and mental health service use, as a proxy measure for mental health problems, 5 years before and 5 years after prostate cancer diagnosis.

Methods

Population‐based registry data were linked with Pharmaceutical Benefits Scheme and Medicare Benefits Schedule data for all prostate cancer patients diagnosed in South Australia between 2012 and 2020 ( n = 13,693). We estimated the proportion and rates of psychotropic medication and mental health service use before and after diagnosis. Multivariable adjusted interrupted time series analyses (ITSA) were conducted to uncover temporal patterns.

Results

Fifteen percent of men commenced psychotropic medications and 6.4% sought out mental health services for the first time after diagnosis. Psychotropic medication use rose from 34.5% 5 years before to 40.3% 5 years after diagnosis, including an increase in use of antidepressants (from 20.7% to 26.0%) and anxiolytics (from 11.3% to 12.8%). Mental health service use increased from 10.2% to 12.1%, with the increase mostly being general practice mental health visits (from 7.8% to 10.6%). Multivariable ITSA indicated a significant rise in medication and service utilisation immediately before and in the first 2 years following prostate cancer diagnosis.

Conclusion

There is a clear increase in psychotropic medication use and mental health service use around the time of prostate cancer diagnosis. Mental health outcomes of men with prostate cancer may be improved with early mental health screening, particularly during the diagnosis process, to enable early intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsMental Health ServicesPsychotropic DrugsHumansMaleAgedMiddle AgedSouth AustraliaAged, 80 and overMental HealthMental DisordersRegistriesInterrupted Time Series AnalysisAnti-Anxiety AgentsAntidepressive AgentsPatient Acceptance of Health Care

Stichwörter der Autor:innen

anxietycancerdepressionmedicare benefits schedulemental healthoncologypharmaceutical benefits schemeprostate cancerpsychotropic medication

Substanzen

Psychotropic DrugsAnti-Anxiety AgentsAntidepressive Agents

Autor:innen und Institutionen

  • Cancer Epidemiology and Population Health Research Group, Allied Health and Human Performance, University of South Australia, Adelaide, South Australia, Australia.
  • School of Public Health, Debre Markos University, Debre Markos, Ethiopia.
  • Central Adelaide Local Health Network, Queen Elizabeth Hospital, Woodville, South Australia, Australia.
  • Urology Unit, Flinders Medical Centre, Bedford Park, South Australia, Australia.
  • Flinders Health and Medical Research Institute, Flinders University, Adelaide, South Australia, Australia.
  • Discipline of Medicine, University of Adelaide, Adelaide, South Australia, Australia.

ORCID-Profile: Tenaw Tiruye, David Roder, Kerri Beckmann

Förderung

  • Movember Foundation
  • Cancer Council South Australia
  • Government of South Australia

Zitieren

APA

Tiruye, T., Hiwase, M., Charlick, M., O'Callaghan, M., Khalid, A., Li, M., FitzGerald, L. M., Caughey, G. E., Ettridge, K., Roder, D., & Beckmann, K. (2024). Temporal trends in medication and service use patterns for mental health issues among men with prostate cancer. Psycho-Oncology. https://doi.org/10.1002/pon.6369

Vancouver

Tiruye T, Hiwase M, Charlick M, O'Callaghan M, Khalid A, Li M, et al. Temporal trends in medication and service use patterns for mental health issues among men with prostate cancer. Psycho-Oncology. 2024. doi:10.1002/pon.6369

BibTeX
@article{Tiruye2024,
  author = {Tiruye, Tenaw and Hiwase, Mrunal and Charlick, Megan and O'Callaghan, Michael and Khalid, Ashna and Li, Ming and FitzGerald, Liesel M and Caughey, Gillian E and Ettridge, Kerry and Roder, David and Beckmann, Kerri},
  title = {Temporal trends in medication and service use patterns for mental health issues among men with prostate cancer},
  journal = {Psycho-Oncology},
  year = {2024},
  doi = {10.1002/pon.6369}
}
Kostenlos starten →